Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders

Mark P. Mattson, Dong Liu

Research output: Contribution to journalArticle

Abstract

As in other cells, neurons use adenosine triphosphate (ATP) as an energy source to drive biochemical processes involved in various cell functions, and produce reactive oxygen species (ROS) as "by products" of oxidative phosphorylation. However, the electrical excitability and structural and synaptic complexity of neurons present unusual demands upon cellular systems that produce or respond to ATP and ROS. Mitochondria in axons and presynaptic terminals provide sources of ATP to drive the ion pumps that are concentrated in these structures to rapidly restore ion gradients following depolarization and neurotransmitter release. Mitochondria may also play important roles in the regulation of synaptic function because of their ability to regulate calcium levels and ROS production. ROS generated in response to synaptic activity are now known to contribute to the regulation of long-term structural and functional changes in neurons, and the best-known example is the nitric oxide radical. The high-energy demands of synapses, together with their high levels of ROS production, place them at risk during conditions of increased stress, which occur in aging, neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, and after acute traumatic and ischemic insults. Energy depletion and/or increased oxidative damage to various synaptic proteins can result in a local dysregulation of calcium homeostasis and synaptic degeneration. Accordingly, recent studies have shown that dietary and pharmacological manipulations that improve energy efficiency and reduce oxyradical production can prevent synaptic degeneration and neuronal death in experimental models of neurodegenerative disorders. A better understanding of the molecular control of subcellular energy production and utilization, and of the functional relationships between energy metabolism, ion homeostasis, and cytoskeletal and vesicular dynamics, will provide novel insight into mechanisms of neuronal plasticity and disease.

Original languageEnglish (US)
Pages (from-to)215-231
Number of pages17
JournalNeuroMolecular Medicine
Volume2
Issue number2
DOIs
StatePublished - 2002

Fingerprint

Neuronal Plasticity
Neurodegenerative Diseases
Reactive Oxygen Species
Oxidative Stress
Adenosine Triphosphate
Presynaptic Terminals
Neurons
Mitochondria
Homeostasis
Biochemical Phenomena
Ion Pumps
Ions
Calcium
Aptitude
Oxidative Phosphorylation
Synapses
Energy Metabolism
Neurotransmitter Agents
Parkinson Disease
Alzheimer Disease

Keywords

  • Alzheimer's
  • ATP
  • Calcium
  • Hippocampus
  • Mitochondria
  • Neurotrophic
  • Parkinson
  • Superoxide

ASJC Scopus subject areas

  • Neuroscience(all)
  • Genetics
  • Cell Biology

Cite this

Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. / Mattson, Mark P.; Liu, Dong.

In: NeuroMolecular Medicine, Vol. 2, No. 2, 2002, p. 215-231.

Research output: Contribution to journalArticle

Mattson, Mark P. ; Liu, Dong. / Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. In: NeuroMolecular Medicine. 2002 ; Vol. 2, No. 2. pp. 215-231.
@article{b0b8540cebdb435183f6575f58fbba2a,
title = "Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders",
abstract = "As in other cells, neurons use adenosine triphosphate (ATP) as an energy source to drive biochemical processes involved in various cell functions, and produce reactive oxygen species (ROS) as {"}by products{"} of oxidative phosphorylation. However, the electrical excitability and structural and synaptic complexity of neurons present unusual demands upon cellular systems that produce or respond to ATP and ROS. Mitochondria in axons and presynaptic terminals provide sources of ATP to drive the ion pumps that are concentrated in these structures to rapidly restore ion gradients following depolarization and neurotransmitter release. Mitochondria may also play important roles in the regulation of synaptic function because of their ability to regulate calcium levels and ROS production. ROS generated in response to synaptic activity are now known to contribute to the regulation of long-term structural and functional changes in neurons, and the best-known example is the nitric oxide radical. The high-energy demands of synapses, together with their high levels of ROS production, place them at risk during conditions of increased stress, which occur in aging, neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, and after acute traumatic and ischemic insults. Energy depletion and/or increased oxidative damage to various synaptic proteins can result in a local dysregulation of calcium homeostasis and synaptic degeneration. Accordingly, recent studies have shown that dietary and pharmacological manipulations that improve energy efficiency and reduce oxyradical production can prevent synaptic degeneration and neuronal death in experimental models of neurodegenerative disorders. A better understanding of the molecular control of subcellular energy production and utilization, and of the functional relationships between energy metabolism, ion homeostasis, and cytoskeletal and vesicular dynamics, will provide novel insight into mechanisms of neuronal plasticity and disease.",
keywords = "Alzheimer's, ATP, Calcium, Hippocampus, Mitochondria, Neurotrophic, Parkinson, Superoxide",
author = "Mattson, {Mark P.} and Dong Liu",
year = "2002",
doi = "10.1385/NMM:2:2:215",
language = "English (US)",
volume = "2",
pages = "215--231",
journal = "NeuroMolecular Medicine",
issn = "1535-1084",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders

AU - Mattson, Mark P.

AU - Liu, Dong

PY - 2002

Y1 - 2002

N2 - As in other cells, neurons use adenosine triphosphate (ATP) as an energy source to drive biochemical processes involved in various cell functions, and produce reactive oxygen species (ROS) as "by products" of oxidative phosphorylation. However, the electrical excitability and structural and synaptic complexity of neurons present unusual demands upon cellular systems that produce or respond to ATP and ROS. Mitochondria in axons and presynaptic terminals provide sources of ATP to drive the ion pumps that are concentrated in these structures to rapidly restore ion gradients following depolarization and neurotransmitter release. Mitochondria may also play important roles in the regulation of synaptic function because of their ability to regulate calcium levels and ROS production. ROS generated in response to synaptic activity are now known to contribute to the regulation of long-term structural and functional changes in neurons, and the best-known example is the nitric oxide radical. The high-energy demands of synapses, together with their high levels of ROS production, place them at risk during conditions of increased stress, which occur in aging, neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, and after acute traumatic and ischemic insults. Energy depletion and/or increased oxidative damage to various synaptic proteins can result in a local dysregulation of calcium homeostasis and synaptic degeneration. Accordingly, recent studies have shown that dietary and pharmacological manipulations that improve energy efficiency and reduce oxyradical production can prevent synaptic degeneration and neuronal death in experimental models of neurodegenerative disorders. A better understanding of the molecular control of subcellular energy production and utilization, and of the functional relationships between energy metabolism, ion homeostasis, and cytoskeletal and vesicular dynamics, will provide novel insight into mechanisms of neuronal plasticity and disease.

AB - As in other cells, neurons use adenosine triphosphate (ATP) as an energy source to drive biochemical processes involved in various cell functions, and produce reactive oxygen species (ROS) as "by products" of oxidative phosphorylation. However, the electrical excitability and structural and synaptic complexity of neurons present unusual demands upon cellular systems that produce or respond to ATP and ROS. Mitochondria in axons and presynaptic terminals provide sources of ATP to drive the ion pumps that are concentrated in these structures to rapidly restore ion gradients following depolarization and neurotransmitter release. Mitochondria may also play important roles in the regulation of synaptic function because of their ability to regulate calcium levels and ROS production. ROS generated in response to synaptic activity are now known to contribute to the regulation of long-term structural and functional changes in neurons, and the best-known example is the nitric oxide radical. The high-energy demands of synapses, together with their high levels of ROS production, place them at risk during conditions of increased stress, which occur in aging, neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, and after acute traumatic and ischemic insults. Energy depletion and/or increased oxidative damage to various synaptic proteins can result in a local dysregulation of calcium homeostasis and synaptic degeneration. Accordingly, recent studies have shown that dietary and pharmacological manipulations that improve energy efficiency and reduce oxyradical production can prevent synaptic degeneration and neuronal death in experimental models of neurodegenerative disorders. A better understanding of the molecular control of subcellular energy production and utilization, and of the functional relationships between energy metabolism, ion homeostasis, and cytoskeletal and vesicular dynamics, will provide novel insight into mechanisms of neuronal plasticity and disease.

KW - Alzheimer's

KW - ATP

KW - Calcium

KW - Hippocampus

KW - Mitochondria

KW - Neurotrophic

KW - Parkinson

KW - Superoxide

UR - http://www.scopus.com/inward/record.url?scp=0036043866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036043866&partnerID=8YFLogxK

U2 - 10.1385/NMM:2:2:215

DO - 10.1385/NMM:2:2:215

M3 - Article

C2 - 12428812

AN - SCOPUS:0036043866

VL - 2

SP - 215

EP - 231

JO - NeuroMolecular Medicine

JF - NeuroMolecular Medicine

SN - 1535-1084

IS - 2

ER -